Hallmarks of cancer: new dimensions
D Hanahan - Cancer discovery, 2022 - AACR
The hallmarks of cancer conceptualization is a heuristic tool for distilling the vast complexity
of cancer phenotypes and genotypes into a provisional set of underlying principles. As …
of cancer phenotypes and genotypes into a provisional set of underlying principles. As …
[HTML][HTML] Gut microbiome and health: mechanistic insights
The gut microbiota is now considered as one of the key elements contributing to the
regulation of host health. Virtually all our body sites are colonised by microbes suggesting …
regulation of host health. Virtually all our body sites are colonised by microbes suggesting …
Targeting the gut and tumor microbiota in cancer
Microorganisms within the gut and other niches may contribute to carcinogenesis, as well as
sha** cancer immunosurveillance and response to immunotherapy. Our understanding of …
sha** cancer immunosurveillance and response to immunotherapy. Our understanding of …
Gut microbiota in colorectal cancer development and therapy
Colorectal cancer (CRC) is one of the commonest cancers globally. A unique aspect of CRC
is its intimate association with the gut microbiota, which forms an essential part of the tumour …
is its intimate association with the gut microbiota, which forms an essential part of the tumour …
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
Y Lu, X Yuan, M Wang, Z He, H Li, J Wang… - Journal of hematology & …, 2022 - Springer
The gut microbiota have long been recognized to play a key role in human health and
disease. Currently, several lines of evidence from preclinical to clinical research have …
disease. Currently, several lines of evidence from preclinical to clinical research have …
Targeting the gut microbiota for cancer therapy
Growing evidence suggests that the gut microbiota modulates the efficacy and toxicity of
cancer therapy, most notably immunotherapy and its immune-related adverse effects. The …
cancer therapy, most notably immunotherapy and its immune-related adverse effects. The …
Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer
SS Jiang, YL **e, XY **ao, ZR Kang, XL Lin, L Zhang… - Cell host & …, 2023 - cell.com
Immune checkpoint blockade therapy with anti-PD-1 monoclonal antibody (mAb) is a
treatment for colorectal cancer (CRC). However, some patients remain unresponsive to PD …
treatment for colorectal cancer (CRC). However, some patients remain unresponsive to PD …
Inflammation: the incubator of the tumor microenvironment
D Denk, FR Greten - Trends in Cancer, 2022 - cell.com
An inflammatory microenvironment, either conferred by an underlying chronic overt or
smoldering inflammatory condition constitutes a prerequisite and fuel to essentially all …
smoldering inflammatory condition constitutes a prerequisite and fuel to essentially all …
Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance
The gut microbiota is a crucial regulator of anti-tumour immunity during immune checkpoint
inhibitor therapy. Several bacteria that promote an anti-tumour response to immune …
inhibitor therapy. Several bacteria that promote an anti-tumour response to immune …
Role of the microbiota in response to and recovery from cancer therapy
Our understanding of how the microbiota affects the balance between response to and
failure of cancer treatment by modulating the tumour microenvironment and systemic …
failure of cancer treatment by modulating the tumour microenvironment and systemic …